Lineage Cell Therapeutics Inc
AMEX:LCTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lineage Cell Therapeutics Inc
AMEX:LCTX
|
US |
|
C
|
China Education Group Holdings Ltd
HKEX:839
|
HK |
|
P
|
Palo Alto Networks Inc
F:5AP
|
US |
|
G
|
Greenlane Renewables Inc
OTC:GRNWF
|
CA |
|
A
|
Atoss Software AG
XHAM:AOF
|
DE |
Wall St Price Targets
LCTX Price Targets Summary
Lineage Cell Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for LCTX is 5.61 USD with a low forecast of 3.03 USD and a high forecast of 9.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LCTX's stock price target?
Price Target
5.61
USD
According to Wall Street analysts, the average 1-year price target for LCTX is 5.61 USD with a low forecast of 3.03 USD and a high forecast of 9.45 USD.
What is the Revenue forecast for Lineage Cell Therapeutics Inc?
Projected CAGR
48%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 48%.
What is the Gross Profit forecast for Lineage Cell Therapeutics Inc?
Projected CAGR
57%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 57%.
